Joseph Hooker
Keine laufenden Positionen mehr
Profil
Joseph Hooker worked as a Senior Director of Clinical Operations at X4 Pharmaceuticals, Pierian Biosciences LLC, and Sandoz Biopharmaceuticals.
He was also a Director of Program Leadership at Biogen, a President, CEO, CFO, and Chief Accounting Officer at NeuroBo Pharmaceuticals, and a Senior Manager of Clinical Trial at DuPont Merck Pharmaceutical Co. Additionally, he earned a Master's in Business Administration from Rider University and an undergraduate degree from Rutgers University, Camden.
Ehemalige bekannte Positionen von Joseph Hooker
| Unternehmen | Position | Ende |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 11.08.2023 |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01.03.2019 |
Pierian Biosciences LLC
 Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2018 |
| MedAvante-ProPhase, Inc. | Geschäftsführer | 01.08.2017 |
Ausbildung von Joseph Hooker
| Rutgers University, Camden | Undergraduate Degree |
| Rider University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Health Services |
| Sandoz Biopharmaceuticals | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
| MedAvante-ProPhase, Inc. |
